PL2162019T3 - Kompozycja lipidowa do poprawy czynności mózgu - Google Patents

Kompozycja lipidowa do poprawy czynności mózgu

Info

Publication number
PL2162019T3
PL2162019T3 PL08766833T PL08766833T PL2162019T3 PL 2162019 T3 PL2162019 T3 PL 2162019T3 PL 08766833 T PL08766833 T PL 08766833T PL 08766833 T PL08766833 T PL 08766833T PL 2162019 T3 PL2162019 T3 PL 2162019T3
Authority
PL
Poland
Prior art keywords
brain function
lipid composition
improving brain
lipid fraction
acid
Prior art date
Application number
PL08766833T
Other languages
English (en)
Inventor
Robert Johan Joseph Hageman
Der Beek Eline Marleen Van
Martine Groenendijk
Patrick Joseph Gerardus Hendrikus Kamphuis
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38457798&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2162019(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of PL2162019T3 publication Critical patent/PL2162019T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Pediatric Medicine (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL08766833T 2007-06-26 2008-06-20 Kompozycja lipidowa do poprawy czynności mózgu PL2162019T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/NL2007/050306 WO2009002145A1 (en) 2007-06-26 2007-06-26 Lipid composition for improving function of brain functioning
EP08766833A EP2162019B1 (en) 2007-06-26 2008-06-20 Lipid composition for improving brain function
PCT/NL2008/050410 WO2009002165A1 (en) 2007-06-26 2008-06-20 Lipid composition for improving brain function

Publications (1)

Publication Number Publication Date
PL2162019T3 true PL2162019T3 (pl) 2012-05-31

Family

ID=38457798

Family Applications (2)

Application Number Title Priority Date Filing Date
PL08766833T PL2162019T3 (pl) 2007-06-26 2008-06-20 Kompozycja lipidowa do poprawy czynności mózgu
PL11195555T PL2436275T3 (pl) 2007-06-26 2008-06-20 Kompozycja lipidowa dla poprawy funkcji mózgu

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL11195555T PL2436275T3 (pl) 2007-06-26 2008-06-20 Kompozycja lipidowa dla poprawy funkcji mózgu

Country Status (11)

Country Link
US (2) US8283335B2 (pl)
EP (2) EP2436275B1 (pl)
CN (1) CN101742926B (pl)
AT (1) ATE538665T1 (pl)
BR (1) BRPI0813320B1 (pl)
DK (1) DK2436275T3 (pl)
ES (2) ES2432345T3 (pl)
PL (2) PL2162019T3 (pl)
PT (2) PT2436275E (pl)
WO (2) WO2009002145A1 (pl)
ZA (1) ZA200909230B (pl)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009002146A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Supporting activities of daily living
WO2009002148A1 (en) 2007-06-27 2008-12-31 N.V. Nutricia Food composition for prodromal dementia patients
PT2170316E (pt) 2007-06-26 2014-01-30 Nutricia Nv Melhoramento de memória em indivíduos com exame de estado mini mental de 24-26
WO2009002145A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
BRPI0818301B1 (pt) † 2007-10-04 2022-02-15 Société des Produits Nestlé S.A. Composições para intensificar a função cognitiva, seu uso e seu método de fabricação, e kit
CN101951923B (zh) 2007-12-20 2013-10-30 N.V.努特里奇亚 含核苷酸/核苷的液态产品
EP2806568B1 (en) * 2008-02-01 2015-12-30 BlackBerry Limited System and method for uplink timing synchronization in conjunction with discontinuous reception
CN102365087A (zh) * 2009-02-02 2012-02-29 马太克生物科学公司 改善认知功能和降低心率的方法
EP2258216A1 (en) * 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Toddlers
EP2258217A1 (en) * 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Children
EP2258218A1 (en) * 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Toddlers
NZ601757A (en) 2010-01-19 2015-01-30 Dsm Ip Assets Bv Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
CN108741083A (zh) * 2010-12-31 2018-11-06 雅培制药有限公司 促进有益细菌生长的中性人乳寡糖
WO2012125020A1 (en) 2011-03-14 2012-09-20 N.V. Nutricia Method for treating neurotrauma
BR122015020126B1 (pt) * 2011-07-21 2022-03-03 Dsm Ip Assets B.V Composição contendo óleo microbiano diluído
WO2013066151A1 (en) 2011-10-31 2013-05-10 N.V. Nutricia Improving recognition
WO2013066152A1 (en) * 2011-10-31 2013-05-10 N.V. Nutricia Method for improving executive function
US20150044138A1 (en) * 2012-03-02 2015-02-12 N.V. Nutricia Method for improving functional synaptic connectivity
WO2013129914A1 (en) 2012-03-02 2013-09-06 N.V. Nutricia Method for improving functional synaptic connectivity
US20140256813A1 (en) * 2013-03-08 2014-09-11 Nordic Naturals, Inc. Methods for the treatment of brain injury using omega-3 fatty acids
WO2014171813A1 (en) 2013-04-17 2014-10-23 N.V. Nutricia Nutritional composition for improving brain function in phenylketonuria
DK3027063T3 (en) * 2013-08-01 2019-02-18 Bunge Loders Croklaan B V OPO-glyceride
WO2015034984A1 (en) * 2013-09-05 2015-03-12 Emory University Nutritional formulas comprising medium chain fatty acids or esters thereof and methods related thereto
US9610302B2 (en) 2013-12-05 2017-04-04 Buriva, LLC. Composition containing phospholipid-DHA and B vitamins
US9233114B2 (en) 2013-12-05 2016-01-12 Buriva, LLC Dietary supplement containing phospholipid-DHA derived from eggs
US9549937B2 (en) 2013-12-05 2017-01-24 Burvia, LLC. Composition containing phospholipid-DHA and folate
US9216199B2 (en) 2013-12-05 2015-12-22 Buriva, LLC Nutritional supplement containing phospholipid-DHA derived from eggs
WO2015084158A1 (en) * 2013-12-06 2015-06-11 N.V. Nutricia A pyrimidine derivative and a fatty acid source for use in the treatment of constipation
WO2015115885A1 (en) 2014-01-31 2015-08-06 N.V. Nutricia Method for reducing white matter lesions, white matter hyperintensities (wmh), leukoaraiosis or periventricular white matter disease in elderly
CN106659220A (zh) * 2014-07-17 2017-05-10 日清奥利友集团株式会社 营养组合物
WO2016013617A1 (ja) * 2014-07-23 2016-01-28 一般財団法人糧食研究会 脳機能改善剤、及び認知機能障害の予防または治療剤
WO2016053085A1 (en) * 2014-09-30 2016-04-07 N.V. Nutricia Composition comprising a uridine source and butyrate producing fibres for preventing gastrointestinal disorders
CN104305192B (zh) * 2014-10-23 2016-05-04 贡岳松 改善老年痴呆症患者记忆的功能性食品及其制备方法
WO2016148561A1 (en) 2015-03-16 2016-09-22 N.V. Nutricia Method for improving bladder function
CA2908184C (en) 2015-10-13 2019-10-22 Roto-gro Inc. Stackable modular rotatable gardening system
WO2017069613A1 (en) 2015-10-23 2017-04-27 N.V. Nutricia Method for improving recognition and/or working memory in hyperphenylalanimenia and phenylketonuria patients
CN108289873A (zh) * 2015-12-04 2018-07-17 雀巢产品技术援助有限公司 用于改善认知的方法
JP6256888B2 (ja) * 2016-02-29 2018-01-10 高知県公立大学法人 健脳食品または健脳飲料およびこれらを投与する方法
WO2017155387A1 (en) 2016-03-08 2017-09-14 N.V. Nutricia Method for supporting memory function and/or cognitive function
BR112018067926A2 (pt) * 2016-03-30 2019-01-02 Nestec Sa composições nutricionais e seus usos
WO2017183970A1 (en) * 2016-04-18 2017-10-26 N.V. Nutricia Linoleic acid and alpha-li nolenic acid for use for reducing early-life stress induced cognitive decline/reduction in neurogenesis
WO2017183956A1 (en) * 2016-04-18 2017-10-26 N.V. Nutricia Linoleic acid and alpha-linolenic acid for use for reducing early-life stress induced cognitive decline
US10456368B2 (en) 2016-09-26 2019-10-29 Garrett E. Wdowin Compositions for mitigating brain trauma and methods thereof
US20180085331A1 (en) * 2016-09-26 2018-03-29 Garrett E. Wdowin Compositions for mitigating head trauma
MA49010B1 (fr) 2017-06-14 2020-11-30 4D Pharma Res Ltd Compositions comprenant une souche bactérienne du genre megasphaera et leurs utilisations
US12403152B2 (en) 2018-06-21 2025-09-02 Societe Des Produits Nestle S.A. Compositions and methods using a nicotinamide adenine dinucleotide (NAD+) precursor and at least one ketone or ketone precursor
WO2020014051A1 (en) * 2018-07-09 2020-01-16 Wdowin Garrett E Compositions for mitigating brain trauma and methods thereof
CN117956908A (zh) 2021-09-17 2024-04-30 N·V·努特里奇亚 适合作为营养组合物或补充剂用于患有脑相关障碍、衰退或疾病的动物的固体组合物
WO2026008342A1 (en) * 2024-07-01 2026-01-08 N.V. Nutricia Composition for improving sleep

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3600197A (en) * 1968-08-27 1971-08-17 Merck & Co Inc Flavor enhancing compositions for foods and beverages
EP0175468A3 (en) * 1984-08-10 1987-07-22 Sentrachem Limited Eicosanoids for use in cancer therapy
JP2525624B2 (ja) * 1987-09-21 1996-08-21 雪印乳業株式会社 多価不飽和脂肪酸配合育児用粉乳
JPH06237734A (ja) * 1991-11-06 1994-08-30 Sanwa Kagaku Kenkyusho Co Ltd 機能後退性疾患用食品組成物
US5378488A (en) 1993-06-10 1995-01-03 Abbott Laboratories Aseptic processing of infant formula
JP3576318B2 (ja) 1996-06-19 2004-10-13 明治乳業株式会社 核酸関連物質含有栄養組成物
JPH10136937A (ja) * 1996-11-08 1998-05-26 Takashi Morita 脳細胞機能向上、血管細胞強化、身体各細胞機能向上栄養総合食品
EP0843972B1 (en) 1996-11-20 2002-07-31 N.V. Nutricia Nutritional composition comprising fats for the treatment of the metabolic syndrome
EP0891719A1 (en) 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
JP3731983B2 (ja) * 1997-08-27 2006-01-05 明治製菓株式会社 痴呆犬の夜鳴き改善薬
US8518882B2 (en) 1998-07-31 2013-08-27 Massachusetts Institute Of Technology Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same
US20070004670A1 (en) * 1998-07-31 2007-01-04 Richard Wurtman Compositions containing citicoline, and methods of use thereof
FR2787799B1 (fr) 1998-12-23 2001-03-09 Rhodia Chimie Sa Composition comprenant une ecorce inorganique et un noyau comportant au moins un compose polyhydroxyle
EP1090636A1 (en) 1999-09-13 2001-04-11 Société des Produits Nestlé S.A. High lipid diet
GB9925709D0 (en) 1999-10-30 1999-12-29 Smithkline Beecham Plc Composition
WO2001082928A1 (en) 2000-05-01 2001-11-08 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism
US6835750B1 (en) * 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
US7226916B1 (en) 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
PL209031B1 (pl) 2001-04-30 2011-07-29 Trommsdorff Arzneimittel Estry urydyny, ich zastosowanie i sposób wytwarzania, oraz kompozycje farmaceutyczne je zawierające
US6942874B2 (en) 2001-05-25 2005-09-13 Linguagen Corp. Nucleotide compounds that block the bitter taste of oral compositions
EP1285590A1 (en) 2001-08-08 2003-02-26 Société des Produits Nestlé S.A. Lipid blends
NL1019368C2 (nl) 2001-11-14 2003-05-20 Nutricia Nv Preparaat voor het verbeteren van receptorwerking.
US20030114415A1 (en) 2001-12-14 2003-06-19 Wurtman Richard J. Compositions and methods for treating and preventing memory impairment using citicoline
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
NZ546785A (en) 2003-10-24 2009-07-31 Nutricia Nv Immunemodulating oligosaccharides
US7090879B2 (en) * 2004-03-18 2006-08-15 Abbott Laboratories Nutritional formula containing select carotenoid combinations
CA2566612C (en) 2004-05-13 2015-06-30 Massachusetts Institute Of Technology Uridine effects on dopamine release
WO2006031683A2 (en) 2004-09-15 2006-03-23 Massachusetts Institute Of Technology Compositions containing uridine, and methods utilizing same
EP1656839A1 (en) 2004-11-11 2006-05-17 N.V. Nutricia Nutrition containing lipid blend
US20060252775A1 (en) 2005-05-03 2006-11-09 Henderson Samuel T Methods for reducing levels of disease associated proteins
FR2885491B1 (fr) * 2005-05-16 2020-03-06 Nutricos Technologies Traitement de la secheresse keratinique par des glycerides
ES2624702T5 (es) 2005-05-23 2020-12-11 Massachusetts Inst Technology Composiciones que contienen PUFA y/o uridina y métodos para su uso
EP2468273A3 (en) 2005-06-20 2012-07-11 Accera, Inc. Method to reduce oxidative damage and improve mitochondrial efficiency
JP5967855B2 (ja) 2005-06-30 2016-08-10 サントリーホールディングス株式会社 日中活動量の低下および／又はうつ症状の改善作用を有する組成物
JP5697293B2 (ja) 2005-06-30 2015-04-08 サントリーホールディングス株式会社 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物
CN101262863B (zh) 2005-07-08 2016-08-31 Dsmip资产公司 用于治疗痴呆和前痴呆相关病症的多不饱和脂肪酸
WO2007058523A1 (en) 2005-11-17 2007-05-24 N.V. Nutricia Composition with docosapentaenoic acid
US20070140992A1 (en) * 2005-12-21 2007-06-21 Lynn Schick Taste masking of essential oils using a hydrocolloid
ATE509624T1 (de) 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
WO2009002146A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Supporting activities of daily living
WO2009002148A1 (en) * 2007-06-27 2008-12-31 N.V. Nutricia Food composition for prodromal dementia patients
PT2170316E (pt) 2007-06-26 2014-01-30 Nutricia Nv Melhoramento de memória em indivíduos com exame de estado mini mental de 24-26
WO2009002145A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
CN101951923B (zh) * 2007-12-20 2013-10-30 N.V.努特里奇亚 含核苷酸/核苷的液态产品
JP5397321B2 (ja) 2009-06-09 2014-01-22 株式会社デンソー 駐車支援システム

Also Published As

Publication number Publication date
US20130018012A1 (en) 2013-01-17
WO2009002145A1 (en) 2008-12-31
PT2436275E (pt) 2013-10-31
ES2432345T3 (es) 2013-12-02
BRPI0813320A2 (pt) 2015-01-06
ATE538665T1 (de) 2012-01-15
EP2436275A1 (en) 2012-04-04
ZA200909230B (en) 2010-09-29
PL2436275T3 (pl) 2013-12-31
WO2009002165A1 (en) 2008-12-31
PT2162019E (pt) 2012-03-20
US8759319B2 (en) 2014-06-24
US20110009357A1 (en) 2011-01-13
CN101742926B (zh) 2017-06-09
ES2378176T3 (es) 2012-04-09
BRPI0813320B1 (pt) 2018-08-07
EP2162019B1 (en) 2011-12-28
DK2436275T3 (da) 2013-10-28
CN101742926A (zh) 2010-06-16
US8283335B2 (en) 2012-10-09
EP2162019A1 (en) 2010-03-17
EP2436275B1 (en) 2013-07-24

Similar Documents

Publication Publication Date Title
PL2162019T3 (pl) Kompozycja lipidowa do poprawy czynności mózgu
WO2008036353A3 (en) Omega-3 diglyceride emulsions
ZA200909227B (en) Food composition for prodromal dementia patients
GB2459809A (en) Fatty acid formulations and methods of use thereof
MX2010004820A (es) Mezcla lipidica para nutricion infantil.
IL210233A0 (en) Omega 3 fatty acid formulations
TW200744463A (en) Nutritional supplement containing long-chain polyunsaturated fatty acids
MX2009004339A (es) Alcoholes de acido graso.
HK1206248A1 (en) Compositions of statins and omega-3 fatty acids
WO2008129358A8 (en) Oil producing microbes and methods of modification thereof
HRP20130531T1 (en) Method for producing a concentrate of eicosapentaenoic and docosahexaenoic acid esters
PH12012501755A1 (en) Compositions and methods for treating and/or preventing cardiovascular disease
WO2011097273A8 (en) Methods and compositions for treating non-alcoholic fatty liver disease with docosahexaenoic acid and n-acetyl l-cysteine
HK1202415A1 (en) Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15-hetre and methods of use thereof
EP1928262A4 (en) METHODS FOR EXTENDING THE LIFETIME OF FOOD COMPOSITIONS CONTAINING POLY-UNSATURATED FATTY ACIDS
GB0514463D0 (en) Use of pinolenic acid
ATE422350T1 (de) Anisinsäure und glyceride enthaltende zusammensetzungen
PL1706106T3 (pl) Zastosowanie wysoko stężonych kompozycji wybranych kwasów tłuszczowych n-3 do leczenia zaburzeń ośrodkowego układu nerwowego
GT200600463A (es) Derivados de carbamoilbenzotriazol como inhibidores de lipasas y fosfolipasas
MX2010003843A (es) Composicion orodispersable que comprende acidos grasos poliinsaturados sin mal olor ni sabor.
AR055659A1 (es) Composicion fungicida
DE60101859D1 (de) Pinolensäure gegen Diabetes
MX2011010935A (es) Composicion basada en petrolato comprendido mas de 10%de silicon para sensacion mejorada al tiempo que permanece estable.
WO2007135518A3 (en) Use of choline-based preparations for the treatment of tinnitus
WO2015031413A3 (en) Transdermal delivery of anastrozole for systemic effect